...Lilly and Co. (NYSE:LLY) for $135 million up front and $1.2 billion in milestones; and Padlock Therapeutics Inc....

...founding CEO of Stromedix Inc., which Bristol Myers Squibb Co. (NYSE:BMY) acquired in 2012; and Padlock Therapeutics Inc....

...was previously COO and head of corporate development at Synlogic Inc. (NASDAQ:SYBX) and CBO of Padlock Therapeutics Inc....

...positions include COO and head of corporate development of Synlogic Inc. (NASDAQ:SYBX) and CBO of Padlock Therapeutics Inc....

...Truex was COO and head of corporate development at Synlogic Inc. (NASDAQ:SYBX) and CBO of Padlock Therapeutics Inc....

...options, deals or specific rights to our investments.” Notable platform investments by the fund include Padlock Therapeutics Inc....

...to developing therapeutics against RNA employ antisense oligos or RNAi. However Gilman, who previously founded Padlock Therapeutics Inc....

...one-time EVP of research at Biogen Inc. (NASDAQ:BIIB), most recently was CEO of autoimmune play Padlock Therapeutics Inc....

...Cambridge, Mass.) named Samantha Truex COO and head of corporate development. She was CBO at Padlock Therapeutics Inc....

...The biggest came in March, when Bristol-Myers Squibb Co. announced plans to buy autoimmune company Padlock Therapeutics Inc....